Study programme 2022-2023 | Français | ||
Pharmacognosie II: phytochimie et étude des médicaments d'origine végétale | |||
Programme component of Bachelor's in Pharmacy (MONS) (day schedule) à la Faculty of Medicine and Pharmacy |
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-B3-PHARMA-024-M | Compulsory UE | DUEZ Pierre | M136 - Chimie thérapeutique et Pharmacognosie |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Français | 48 | 0 | 0 | 0 | 0 | 6 | 6.00 | 2nd term |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-CTPH-310 | Pharmacognosie II: phytochimie et étude des médicaments d'origine végétale | 48 | 0 | 0 | 0 | 0 | Q2 | 100.00% |
Programme component | ||
---|---|---|
UM-B2-PHARMA-004-M Organic Chemistry II | ||
UM-B2-PHARMA-010-M Pharmacognosy I - Introduction to Pharmacognosy |
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
The UE is addressing the issue of natural materials with the aim of providing the future Pharmacist with general conceptual skills that will enable him/her : to analyze the structure of new complex molecules to place them in a context of known biosynthetic structures or pathways; to relate the structures, the pharmacological activities and the traditional use of medicinal plants to understand the methods of analysis described in the Pharmacopoeia monographs. Seminars in herbal medicine will enable the student to identify the place of medicinal plants in modern therapeutics, by specifying the benefit-risk balance.
UE Content: description and pedagogical relevance
This UE is the continuation of the EU "Pharmacognosy I - Introduction to Pharmacognosy - UM-B2-PHARMA-010-M" The UE develops strong foundations of phytochemistry, supported by the study of active components biosyntheses; the analytical and pharmacological aspects are also deepened for the natural compounds which do not have an equivalent in traditional drugs. It aims at understanding the position of medicinal plants in modern therapy, taking into account the ratio benefits-risks.
Prior Experience
Organic and analytical chemistry
Pharmacognosie I
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-CTPH-310 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-CTPH-310 |
|
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-CTPH-310 | http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000212.jsp |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-CTPH-310 | Bruneton J. (2016) "Pharmacognosie. Phytochimie. Plantes médicinales", 5ème Ed., Tec & Doc, Paris Evans W.C. (2002) "Trease and Evans Pharmacognosy", 15th Ed., W.B. Saunders, Edinburgh Dewick P.M. (2009) "Medicinal natural products. A biosynthetic approach", 3rd Ed., John Wiley & Sons Ltd, Chichester Wichtl et Anton (2003) "Plantes thérapeutiques : tradition, pratique officinale, science et thérapeutique" (2ème Ed), Tec&Doc, Paris Heinrich M. et al. (2018) "Fundamentals of Pharmacognosy and Phytotherapy", 3rd Edition, Elsevier, Amsterdam |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-CTPH-310 | Not applicable |
Grade Deferrals of AAs from one year to the next
AA | Grade Deferrals of AAs from one year to the next |
---|---|
M-CTPH-310 | Authorized |
Term 2 Assessment - type
AA | Type(s) and mode(s) of Q2 assessment |
---|---|
M-CTPH-310 |
|
Term 2 Assessment - comments
AA | Term 2 Assessment - comments |
---|---|
M-CTPH-310 | Not applicable |
Term 3 Assessment - type
AA | Type(s) and mode(s) of Q3 assessment |
---|---|
M-CTPH-310 |
|
Term 3 Assessment - comments
AA | Term 3 Assessment - comments |
---|---|
M-CTPH-310 | Not applicable |